It’s one thing to make a mistake once, but when you make the same mistake twice and with in a short amount of time right after being reinstated for the first mistake. This is what happened to Jenry Mejia. You have to figure this suspension signals the end of his Mets career and definitely a signal of a much deeper problem for Mejia.
The right-hander was suspended April 11 after testing positive for Stanozolol and said in a statement then “I can honestly say I have no idea how a banned substance ended up in my system.”
This time he tested positive for Stanozolol and Boldenone, the commissioner’s office said less than an hour before the first pitch of New York’s 4-0 victory over San Diego. The two penalties cost Mejia $2,112,869 of his $2,595,000 salary this season.
“I was totally shocked. Incredulous — whatever the right term is — that this could happen so swiftly on the heels of a past suspension. Couldn’t understand it,” Mets general manager Sandy Alderson said.
Mejia returned to the mound July 12 and was 1-0 in seven games, pitching 7 1-3 scoreless innings. Because of the first suspension, he would have been ineligible for the postseason this year — if the Mets make it that far. He would, however, be eligible for the 2016 postseason.
The first time Mejia was banned, Mets officials expressed disappointment and anger. This time, Alderson was practically beside himself.
“I think not surprisingly there’s a tremendous amount of disappointment. I think to some extent, anger. To some extent, amazement that this could happen so soon after a previous suspension was completed,” he said. “And some sadness, in the sense that this is having a tremendously adverse effect on a very promising major league career — and that’s a shame. But the rules are the rules. We support the rules. And this is the consequence of making bad choices.”